
Kaitlan Collins @kaitlancollins
Merck says it will seek authorization for the first antiviral pill for Covid after its drug was shown in a clinical trial to cut the risk of hospitalization or death in half when given to high-risk people early in their infections. https://t.co/n5hcB8v0vz — PolitiTweet.org